Okla. Stat. tit. 63, § 63-1-756.4

A. The qualified physician providing an abortion-inducing drug

shall examine the woman in person, and prior to providing an

abortion-inducing drug, shall:

1. Independently verify that a pregnancy exists;

2. Determine the woman's blood type, and if she is Rh negative,

be able to and offer to administer RhoGAM at the time of the

abortion;

3. Inform the patient that she may see the remains of her

unborn child in the process of completing the abortion; and

4. Document, in the woman's medical chart, the gestational age

and intrauterine location of the pregnancy, and whether she received

treatment for Rh negativity, as diagnosed by the most accurate

standard of medical care.

B. A qualified physician providing an abortion-inducing drug

shall be credentialed and competent to handle complication

management including emergency transfer, or shall have a signed

contract with an associated physician who is credentialed to handle

complications and be able to produce that signed contract on demand

by the pregnant woman, by the State Board of Medical Licensure and

Supervision or by the State Department of Health. Every pregnant

woman to whom a qualified physician provides any abortion-inducing

drug shall be given the name and phone number of the associated

physician.

C. The qualified physician providing any abortion-inducing drug

or an agent of the qualified physician shall schedule a follow-up

visit for the woman at approximately seven (7) to fourteen (14) days

after administration of the abortion-inducing drug to confirm that

the pregnancy is completely terminated and to assess the degree of

bleeding. The qualified physician shall make all reasonable efforts

to ensure that the woman returns for the scheduled appointment. A

brief description of the efforts made to comply with this subsection

including the date, time and identification by name of the person

making such efforts, shall be included in the woman's medical

record.